» Articles » PMID: 29681456

Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2018 Apr 24
PMID 29681456
Citations 521
Authors
Affiliations
Soon will be listed here.
Abstract

Triple-negative breast cancer (TNBC) is an aggressive subtype that frequently develops resistance to chemotherapy. An unresolved question is whether resistance is caused by the selection of rare pre-existing clones or alternatively through the acquisition of new genomic aberrations. To investigate this question, we applied single-cell DNA and RNA sequencing in addition to bulk exome sequencing to profile longitudinal samples from 20 TNBC patients during neoadjuvant chemotherapy (NAC). Deep-exome sequencing identified 10 patients in which NAC led to clonal extinction and 10 patients in which clones persisted after treatment. In 8 patients, we performed a more detailed study using single-cell DNA sequencing to analyze 900 cells and single-cell RNA sequencing to analyze 6,862 cells. Our data showed that resistant genotypes were pre-existing and adaptively selected by NAC, while transcriptional profiles were acquired by reprogramming in response to chemotherapy in TNBC patients.

Citing Articles

Patient-Derived Organoids for Guiding Neoadjuvant Chemotherapy in Bilateral Primary Breast Cancer: A Case Report.

Cao M, Wang R, Cheng X, Yu H, Tong Q, Yao Y Onco Targets Ther. 2025; 18:319-324.

PMID: 40066235 PMC: 11892363. DOI: 10.2147/OTT.S484293.


Analyze the Diversity and Function of Immune Cells in the Tumor Microenvironment From the Perspective of Single-Cell RNA Sequencing.

Ma L, Luan Y, Lu L Cancer Med. 2025; 14(5):e70622.

PMID: 40062730 PMC: 11891933. DOI: 10.1002/cam4.70622.


Examining patient-specific responses to PARP inhibitors in a novel, human induced pluripotent stem cell-based model of breast cancer.

Weddle C, Blancard M, Uche N, Pongpamorn P, Cejas R, Burridge P NPJ Precis Oncol. 2025; 9(1):53.

PMID: 40000798 PMC: 11862011. DOI: 10.1038/s41698-025-00837-5.


Molecular mechanism of ZC3H13 -mediated ferroptosis in doxorubicin resistance of triple negative breast cancer.

Huang L, Han L, Liang S, Han G Cell Biol Toxicol. 2025; 41(1):52.

PMID: 40000487 PMC: 11861033. DOI: 10.1007/s10565-024-09980-4.


Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells.

Xie C, Chan L, Pang Y, Shang Y, Wang W, Zhao L Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39998626 DOI: 10.1007/s00210-025-03927-0.


References
1.
Finak G, McDavid A, Yajima M, Deng J, Gersuk V, Shalek A . MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 2015; 16:278. PMC: 4676162. DOI: 10.1186/s13059-015-0844-5. View

2.
Auton A, Brooks L, Durbin R, Garrison E, Kang H, Korbel J . A global reference for human genetic variation. Nature. 2015; 526(7571):68-74. PMC: 4750478. DOI: 10.1038/nature15393. View

3.
Yates L, Gerstung M, Knappskog S, Desmedt C, Gundem G, Van Loo P . Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat Med. 2015; 21(7):751-9. PMC: 4500826. DOI: 10.1038/nm.3886. View

4.
Lohr J, Adalsteinsson V, Cibulskis K, Choudhury A, Rosenberg M, Cruz-Gordillo P . Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat Biotechnol. 2014; 32(5):479-84. PMC: 4034575. DOI: 10.1038/nbt.2892. View

5.
Tung P, Blischak J, Hsiao C, Knowles D, Burnett J, Pritchard J . Batch effects and the effective design of single-cell gene expression studies. Sci Rep. 2017; 7:39921. PMC: 5206706. DOI: 10.1038/srep39921. View